AEON Biopharma, Inc. (AEON)
CIK 1837607 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for AEON Biopharma, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Nov 3, 2026 | 8-K | 0001837607-26-000081 |
| Nov 3, 2026 | 424B3 | 0001837607-26-000082 |
| Oct 26, 2026 | DEF 14A | 0001837607-26-000074 |
| Oct 23, 2026 | 8-K | 0001837607-26-000071 |
| Oct 13, 2026 | PRE 14A | 0001837607-26-000068 |
| Sep 30, 2026 | 8-K | 0001837607-26-000064 |
| Aug 21, 2026 | 3 | 0000935836-26-000438 |
| Aug 21, 2026 | 4 | 0000935836-26-000440 |
| Aug 21, 2026 | SCHEDULE 13G | 0000935836-26-000442 |
| Aug 12, 2026 | 8-K | 0001837607-26-000061 |
| Aug 12, 2026 | 10-Q | 0001837607-26-000062 |
| Aug 3, 2026 | 8-K | 0001837607-26-000057 |
| Jul 23, 2026 | 8-K | 0001837607-26-000055 |
| Jul 21, 2026 | SCHEDULE 13G | 0001440771-26-000012 |
| Jul 15, 2026 | 8-K | 0001837607-26-000052 |
| Jul 15, 2026 | 424B4 | 0001104659-26-083680 |
| Jul 13, 2026 | S-1MEF | 0001104659-26-083252 |
| Jul 13, 2026 | EFFECT | 9999999995-26-002285 |
| Jul 9, 2026 | S-1/A | 0001104659-26-082167 |
| Jul 8, 2026 | S-1 | 0001104659-26-081860 |
| Jun 22, 2026 | 4 | 0001104659-26-076515 |
| Jun 22, 2026 | 4 | 0001104659-26-076513 |
| Jun 22, 2026 | 4 | 0001104659-26-076511 |
| Jun 22, 2026 | 4 | 0001104659-26-076509 |
| Jun 22, 2026 | 4 | 0001104659-26-076510 |